Conditions and diseases
Register as a stakeholder
Stopping antiviral treatment in HBeAg-negative disease:- Further research should be undertaken to evaluate the clinical and c...
ALT values for children and young people:- Further research should be undertaken to examine whether the upper limit of normal...
Long-term safety of tenofovir disoproxil in chronic hepatitis B:- Further research should be undertaken to determine the long...
Prophylactic treatment in people receiving immunosuppressive therapy:- Further research should be undertaken to determine whe...
How can case-finding for hepatitis B and C be improved? What modifiable factors influence whether or not specific groups at i...
How many people in the UK are infected with chronic hepatitis B and C and which subgroups of the population do they come from...
How cost effective are cohort testing programmes:
- as a stand-alone programme, or
- as an extension of the NHS Hea...
How can the uptake of hepatitis C treatment be improved? What factors influence whether or not specific groups at increased r...
What cost-effective interventions can be used to increase hepatitis B case-finding among migrant populations in primary and s...
What cost-effective interventions ensure continuity of care for prisoners who are diagnosed with chronic hepatitis B or C in ...
Bolton Integrated Drug and Alcohol Service (BiDAS) Steroid Clinic
Improving the uptake of Hepatitis B screening and vaccination in at-risk groups attending the sexual health service
Use of transient elastography to assess liver disease in people with chronic hepatitis B
Using the hepatitis B surface antigen (HBsAg) quantitative assay test to evaluate patient response to treatment for chronic hepatitis B virus infection
Hepatitis information and testing in Sheffield: Outreach pilot for high prevalence communities
Yorkshire and the Humber Hepatitis Project
The Spectrum hepatitis C support service.
Mind the Gap
Hepatitis C GP Awareness Project
Developing a Greater Manchester Hepatitis C Service Specification